Karen H. Lu, MD

home / authors / karen-h.-lu-md

Articles

Karen H. Lu, MD

Karen H. Lu, MD, on Next Steps in Evaluating Genetic Testing in Underrepresented Minorities

Karen H. Lu, MD
July 22nd 2020

The MD Anderson Cancer Center expert discussed further research in delivering online accessible genetic testing.

Karen H. Lu, MD

Karen H. Lu, MD, on Key Takeaways from Online Genetic Testing

Karen H. Lu, MD
July 16th 2020

The MD Anderson Cancer Center expert spoke about the key takeaways from a trial designed to test whether pre and/or post-test genetic counseling is needed to optimally deliver online accessible genetic testing.

Karen H. Lu, MD

Karen H. Lu, MD, on Genetic Testing From Patients’ Living Rooms

Karen H. Lu, MD
July 6th 2020

At the 2020 ASCO Virtual Scientific Program, Karen H. Lu, MD, presented on findings from the MAGENTA trial, designed to test whether pre and/or post-test genetic counseling is needed to optimally deliver online accessible genetic testing.

genetic testing

Karen H. Lu, MD, on Delivering Online, Accessible Genetic Testing

Karen H. Lu, MD
July 4th 2020

The expert discussed study methods and results from the MAGENTA trial evaluating pre and/or post-test genetic counseling.

Latest Updated Articles

Treosulfan plus fludarabine is now approved by the FDA as an injection for allo-HSCT conditioning for patients with AML or MDS.
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: July 3rd 2025
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes